TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.30$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Upstream Bio, Inc. (UPB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -133 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow UPB
Line item 2022 2023 2024 2025
-19 -38 -59 -133
0.0 0.1 0.1 -1.3
1.3 3.4 6.0 10
3.4 -4.3 1.9 0.6
0.1 0.1 0.5 0.2
-0.1 -83 -59 -93
10.0 130 419 2.4
-9.1 8.8 300 -224
-19 -38 -60 -133

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?